- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Neoplasms, Locally Advanced in Poland
Total 852 results
-
Brown UniversityThe Miriam HospitalCompletedProstate CancerUnited States
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast CancerSpain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama
-
Incyte CorporationTerminatedProstate CancerUnited States
-
NewLink Genetics CorporationTerminatedPancreatic Cancer | Locally Advanced Malignant Neoplasm | Pancreatic Carcinoma Non-resectableUnited States
-
Eli Lilly and CompanyCompletedProstate CancerBelgium, Germany, Spain, Poland, Czechia, Hungary, Italy
-
Amsterdam UMC, location VUmcCompletedPancreatic Cancer | Locally Advanced Pancreatic Carcinoma (LAPC) | Non-metastasized Unresectable Pancreatic CarcinomaNetherlands
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, Spain, France, Italy, Korea, Republic of, Poland
-
VA Office of Research and DevelopmentRecruitingMetastatic Prostate CancerUnited States
-
AmgenCompletedSarcoma | Lymphoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors | Metastatic Cancer | Solid Tumors | Carcinoid | Locally AdvancedUnited States, Spain, Poland
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Antisoma ResearchCompletedProstate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Locally Advanced Malignant Solid Neoplasm | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Locally Advanced Clear Cell Renal Cell CarcinomaUnited States
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
NovaceaAventis PharmaceuticalsUnknownProstate CancerCanada, United States
-
Ionis Pharmaceuticals, Inc.CompletedCastrate-Resistant Prostate CancerUnited States, Puerto Rico, Hungary, Romania, Russian Federation, Poland
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
VA Office of Research and DevelopmentNational Cancer Institute (NCI); Agency for Healthcare Research and Quality...Completed
-
DendreonCompletedProstate CancerUnited States, Canada
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, United Kingdom, Kenya, Turkey, Hungary, Colombia, India, Oman, Saudi Arabia, Poland, Uganda, United... and more
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
University of Michigan Rogel Cancer CenterNational Institutes of Health (NIH); Myrexis Inc.; Veracyte, Inc.; MDx HealthRecruiting
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
University Medical Center GroningenDutch Cancer SocietyRecruitingAndrogen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (ADOPT)Prostate CancerNetherlands
-
AstraZenecaCompletedProstate CancerSweden, United States, Australia, France, United Kingdom, Poland, Finland, Netherlands, Norway, Belgium, Canada, Indonesia, Denmark, Switzerland
-
MedImmune LLCCompletedProstate CancerUnited States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
-
University of Michigan Rogel Cancer CenterMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkRecruitingNeuroendocrine Tumors | Prostate Cancer MetastaticUnited States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
Janssen Biotech, Inc.Active, not recruitingProstate Cancer | Prostatic NeoplasmUnited States
-
GP-PharmCompletedProstate CancerUnited States
-
OHSU Knight Cancer InstituteLance Armstrong FoundationCompletedOsteoporosis | Prostatic NeoplasmUnited States
-
University of WashingtonNational Cancer Institute (NCI); Canary Foundation; CureBRCARecruitingProstate CarcinomaUnited States
-
Deciphera Pharmaceuticals LLCCompletedLocally Advanced or Metastatic Solid TumorUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerNetherlands, Belgium, Germany, Russian Federation, South Africa, Hungary, Romania, Poland
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, Argentina, Italy, Mexico, Spain, United Kingdom, Netherlands, Australia, Colombia, Belgium, Austria, Denmark, Puerto Rico, France, Israel, Peru, Romania, Russian Federation, Hungary, Brazil, Germany, Czech Republic, C... and more
-
SanofiCompletedProstatic NeoplasmFrance, Canada, Poland, Italy, Netherlands, Portugal, Spain, Belgium, Czech Republic, Mexico, Australia, Chile, United Kingdom
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Prostate Cancer MetastaticFrance, Switzerland, Spain, Italy
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Tavanta TherapeuticsCompletedMetastatic Prostate Cancer | Metastatic Castration-sensitive Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Hungary, France, Poland, Puerto Rico, Sweden
-
DendreonTerminatedCastration-Resistant Prostate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
OHSU Knight Cancer InstituteOregon Health and Science University; Radiological Society of North AmericaTerminatedStage III Rectal Cancer AJCC v7 | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Rectal Cancer AJCC v7 | Stage IIIC Rectal Cancer AJCC v7 | Locally Advanced Rectal CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Ureter Cancer AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Locally Advanced Ureter Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Localized Renal Pelvis and Ureter Urothelial Carcinoma | Stage II Bladder... and other conditionsUnited States, Guam
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
SanofiCompletedProstate CancerKorea, Republic of, Spain, United States, Argentina, Peru, Romania, Taiwan, United Kingdom, Belgium, Chile, Netherlands, Australia, Germany, Tunisia, Brazil, Canada, France, Hungary, Poland, Russian Federation, South Africa, Turkey
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States